Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?-Reference-Cited by-同舟云学术

Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?

Published:2020-12 Issue: Volume:419 Page:117169
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Terhoeven Pauline,Seybold Julia,Utz Kathrin S.,Nickel Florian T.,Lee De-Hyung,Linker Ralf A.

Funder

Biogen

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference29 articles.

1. Incidence and prevalence of CIDP and the association of diabetes mellitus;Laughlin;Neurology.,2009

2. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori prefecture, Japan;Kusumi;Psychiatry Clin. Neurosci.,1995

3. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England;Lunn;J. Neurol. Neurosurg. Psychiatry,1999

4. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): clinical features, diagnosis, and current treatment strategies;Reynolds;Rhode Island Med. J.,2016

5. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy;Hughes;JPNS,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy;Neurology International;2023-03-10

2. Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy;Journal of the Peripheral Nervous System;2022-03-15

3. Immune-globulin;Reactions Weekly;2020-11